Clinical Trial Update: Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer [NA]

View source ↗

Summary

This clinical trial update notes a completed study evaluating Cytoxan (cyclophosphamide), epirubicin, and capecitabine in women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cytoxan (cyclophosphamide)
• Epirubicin (epirubicin)

Snippet

Sponsor: Craig A. Bunnell, MD, MPH | Conditions: Breast Cancer, Stage I Breast Cancer | NA | Status: COMPLETED